Style | Citing Format |
---|---|
MLA | Zinatizadeh MR, et al.. "The Nuclear Factor Kappa B (Nf-Kb) Signaling in Cancer Development and Immune Diseases." Genes and Diseases, vol. 8, no. 3, 2021, pp. 287-297. |
APA | Zinatizadeh MR, Schock B, Chalbatani GM, Zarandi PK, Jalali SA, Miri SR (2021). The Nuclear Factor Kappa B (Nf-Kb) Signaling in Cancer Development and Immune Diseases. Genes and Diseases, 8(3), 287-297. |
Chicago | Zinatizadeh MR, Schock B, Chalbatani GM, Zarandi PK, Jalali SA, Miri SR. "The Nuclear Factor Kappa B (Nf-Kb) Signaling in Cancer Development and Immune Diseases." Genes and Diseases 8, no. 3 (2021): 287-297. |
Harvard | Zinatizadeh MR et al. (2021) 'The Nuclear Factor Kappa B (Nf-Kb) Signaling in Cancer Development and Immune Diseases', Genes and Diseases, 8(3), pp. 287-297. |
Vancouver | Zinatizadeh MR, Schock B, Chalbatani GM, Zarandi PK, Jalali SA, Miri SR. The Nuclear Factor Kappa B (Nf-Kb) Signaling in Cancer Development and Immune Diseases. Genes and Diseases. 2021;8(3):287-297. |
BibTex | @article{ author = {Zinatizadeh MR and Schock B and Chalbatani GM and Zarandi PK and Jalali SA and Miri SR}, title = {The Nuclear Factor Kappa B (Nf-Kb) Signaling in Cancer Development and Immune Diseases}, journal = {Genes and Diseases}, volume = {8}, number = {3}, pages = {287-297}, year = {2021} } |
RIS | TY - JOUR AU - Zinatizadeh MR AU - Schock B AU - Chalbatani GM AU - Zarandi PK AU - Jalali SA AU - Miri SR TI - The Nuclear Factor Kappa B (Nf-Kb) Signaling in Cancer Development and Immune Diseases JO - Genes and Diseases VL - 8 IS - 3 SP - 287 EP - 297 PY - 2021 ER - |